Midday Report: Geron (GERN) Gains on August 5

Equities Staff  |

Today Geron Corp. (NASDAQ: GERN) is trading 22.30% up.

The latest price, as of 11:56:23 est, was $2.50. Geron has moved $0.455 so far today.

2,989,661 shares have exchanged hands.

As of the previous close, Geron has a YTD change of 101.64%. The company is set to release earnings on 2022-08-15.

For technical charts, analysis, and more on Geron visit the company profile.

About Geron Corp.

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The Company currently is conducting two Phase 3 clinical trials: IMerge in lower risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis.

To get more information on Geron Corp. and to follow the company's latest updates, you can visit the company's profile page here: Geron Corp.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

These Stocks are Sending a Signal (like Amazon in 2008)
It Isn’t a Recession Until This Group of Economists Says So
What You Should Know About Europe's Energy Wars
Meatless Meats and Smokeless Smokes
Mixed Wireless Recovery at AT&T, Verizon, T-Mobile: Jeff Kagan
The Strong Dollar Is a Problem for Stocks



Market Movers

Sponsored Financial Content